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Abstract
Background: Infected bone defect poses a great challenge for orthopedists because it is difficult to cure.
Tissue-engineered bone based on the human mesenchymal stem cells (hMSCs), has currently taken a promising
treatment protocol in clinical practice. In a previous study, a porous hydroxyapatite/fibronectin/alginate (PHA/FN/ALG)
composite scaffold displayed favorable biological properties as a novel scaffold, which was considered better than
single-material scaffolds. In addition, Wnt11 has been demonstrated to play an important role in the development of
osteoblasts, but until recently, its role in the osteogenic differentiation of hMSCs in infectious environment remained
unclear.
Methods: In this study, we constructed a PHA/FN/ALG composite scaffold with layer-by-layer technology. Furthermore,
we also constructed Wnt11-silenced (RNAi) and -overexpressing hMSCs by lentiviral transduction. The gene
transduction efficacy was confirmed by quantitative PCR assay and Western blot analysis. Tissue-engineered bone was
constructed with hMSCs and PHA/FN/ALG composite scaffolds, and then was implanted into an infected bone defect
model for evaluating the osteogenic capacity by quantitative PCR, gross observation, micro-CT and histology analysis.
Results: All those cells showed similar adhesion abilities and proliferation capacities in scaffolds. After
tissue-engineered bone implantation, there were high levels of systemic inflammatory factors in vivo, which
significantly declined three days after antibiotic therapy. One or two months after implantation, the results
of osteogenic-related gene analyses, gross observation, micro-CT and histology consistently showed that the
Wnt11 over-expression hMSC group displayed the strongest osteogenesis capacity, whereas the Wnt11-RNAi
hMSC group displayed inferior osteogenesis capacity, when compared with the other cell-containing
groups. However, the blank control group and the only composite scaffold without cell implantation group
both showed extremely weak osteogenesis capacity.
Conclusion: Our results revealed that the Wnt11 gene plays an important role in hMSCs for enhancing the
osteogenesis in an infectious environment.
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Background
Infected bone defect remains one of the greatest chal-
lenges for orthopedists because it is clinically difficult to
treat and eradicate [1]. It has been reported that
approximately 5–10 % of open fractures will evolve into
osteomyelitis or bone nonunion, which often subse-
quently lead to infected bone defects [2, 3]. Because of
the long treatment time and low cure rate, infected bone
defects can be devastating and associated with physical
and psychological damage for patients as well as eco-
nomic loss [4].
The common treatment modalities for infected bone de-
fect mainly include repeated debridement, which is the
one of the most important surgical principles [5]. Mean-
while, traditional antibiotic therapy has been employed
generally, although it is difficult to produce an effective
local antibiotic concentration despite the high serum con-
centration [5, 6]. Therefore, when necessary, local anti-
biotic delivery systems such as the antibiotic polymethyl
methacrylate (PMMA) bead, etc., are often used to pro-
mote the local antibiotic concentration for killing bacteria,
and create a certain therapeutic effect [5]. However, the
therapeutic efficacy is still not very satisfactory. Therefore,
it is important to further investigate the potential mecha-
nisms and therapies for bone formation in patients with
infected bone defects.
Open bone fractures are generally contaminated by
pathogenic microorganisms, including Staphylococcus
aureus, Staphylococcus epidermidis, streptococcus, and
Klebsiella, etc. [7]. Bacterial microorganisms will enter
the fractured site and release coagulase or virulence fac-
tors, such as exotoxins and endotoxins, which may not
only damage soft tissue or bone tissue but also hinder
bone formation at the injury site by downregulating the
osteogenic capacity of mesenchymal stem/stromal cells
(MSCs) [8–10]. Recently, bone tissue engineering using
MSCs has offered an alternative treatment approach for
infected bone defect [11]. Bone regeneration in vivo is a
complicated process, however, and demands a large
number of MSCs in the fracture regions [12]. In
addition, studies have indicated that composite scaffolds
are superior to single-material scaffolds in terms of
mechanical properties and bioactivity [13, 14]. Many
researchers have thus attempted to modify single-
material scaffolds with one or multiple materials for use
in bone tissue engineering [13, 15, 16]. Compared with
other widely used materials, porous hydroxyapatite
(PHA) has gained interest because of its osteoinduction
and osteoconduction properties in spite of its poor per-
formance in cell adhesion and migration [14]. Another
biomaterial of interest is alginate (ALG), a natural poly-
saccharide extracted from brown algae that is suggested
to have antibacterial function [17]. In addition, fibronec-
tin (FN) is also often used to modify the scaffold surface
because of its cell adhesion properties [18]. In some
studies, investigators have fabricated the PHA/ALG
composite scaffold with the aim of possessing antibiotic
function and good cell adhesion properties [19, 20]. Fur-
thermore, when the composite scaffold PHA/ALG was
modified to include FN (PHA/FN/ALG), it displayed fine
properties for nerve regeneration [20]. In this study, we
constructed a PHA/FN/ALG composite scaffold using
layer-by-layer technology to possess antibiotic function
and fine cell adhesive properties.
Studies have demonstrated that Wnt11 has been
implicated in playing an important role in skeletal devel-
opment [21]. Combined with transforming growth factor
beta-1 (TGF-β1), Wnt11 may promote the chondrogenic
differentiation of MSCs [22]. Furthermore, Wnt11 has
been shown to promote osteoblast maturation and
mineralization [23]. However, its role in osteogenesis of
MSCs in an infectious environment remains to be
elucidated.
We hypothesized that Wnt11 plays an important role in
the osteogenesis of human mesenchymal stem/stromal
cells (hMSCs) in an infected bone defect. Here, we fabri-
cated a composite scaffold of PHA/ALG/FN. Using lenti-
virus technology, we also constructed hMSCs that
overexpressed or silenced (via RNA interference) Wnt11.
These modified hMSCs were then loaded on the PHA/
ALG/FN composite scaffold and transplanted into an
infected bone defect rabbit model. Subsequently, we mon-
itored serological inflammatory markers using enzyme-
linked immunosorbent assay (ELISA). One month after
implantation, the osteogenesis capacity in different grafts
was evaluated by X-ray photography, gross observation,
micro-computed tomography (micro-CT), quantitative
PCR, and histological analysis. We found that Wnt11




All experimental procedures were approved by the
Kunming General Hospital Committee on Ethics for the
care and use of laboratory animals. Before bone marrow
collection, approval and informed consent were obtained
from the Institutional Review Board and the donors.
Culture of hMSCs
hMSCs were obtained according to a previously described
method [24]. Briefly, approximately 8 ml bone marrow was
aspirated from seven male and five female donors, 31–56
years old. Mononuclear cells were isolated by Percoll density
gradient centrifugation (1.073 g/ml; Sigma, St. Louis, Mis-
souri USA) at 900 × g for 20 minutes. The cells were rinsed
with phosphate-buffered saline (PBS) and plated in a 25 cm2
cell culture flask (Costar Corning, NY, USA). The expansion
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medium used was Dulbecco’s modified Eagle’s medium/F12
(DMEM/F12; HyClone, Logan, Utah, USA) supplemented
with 10 % fetal calf serum (HyClone) and 100 U/ml penicil-
lin–streptomycin (HyClone). During culture, the medium
was changed every 3 days. Cells were passaged after reach-
ing 90 % confluence and then used for experiments (pas-
sage 1).
Fabrication of PHA/FN/ALG composite scaffold
Cylindrical PHA (diameter: 0.5 cm; thickness: 1.0 cm)
was provided by the Engineering Research Center in
Biomaterials (Sichuan University, ChengDu, China). FN
(10 μg/ml) and ALG (2 w/v %) solutions were prepared
beforehand. PHA samples were initially immersed in FN
solutions for 24 hours at 37 °C to obtain a precursor
scaffold. The composite scaffold was formed by dipping
PHA/FN into ALG solution for another 24 hours at 37 °
C. The final composite scaffold of PHA/FN/ALG was
prepared for subsequent assays after dehydration at 4 °C
for 24 hours and radio-sterilization.
Lentiviral vector construction and virus production
Lentiviral vector (pGC-LV-GFP) for expressing Wnt11
short hairpin RNA (Wnt11-shRNA-LV) was purchased
from Genechem Corp. (Shanghai, China). The small inter-
fering RNA (siRNA) sequence targeting Wnt11 was 5′-
TGACTTCTGCATGAAGAAT-3′. As a control, we used
a green fluorescent protein (GFP) lentiviral vector with a
scrambled siRNA sequence (sequence: 5′-TACTGAC-
GATGATACGTAT-3′). The designed oligonucleotide frag-
ments were synthesized and cloned into pGC-LV-GFP
vectors (GeneChem, Shanghai, China). The target recom-
binant lentiviral vector and empty vector were transfected
and amplified in 293 cells using Lipofectamine 2000 (Invi-
trogen, Carlsbad, California, USA) according to the manu-
facturer’s instructions. Viral titers were collected from the
supernatant of 293 cells and detected by optical density
(OD). After being collected, the lentivirus was prepared at
a titer of 109 transfection units/ml for subsequent assays.
To obtain Wnt11 overexpression lentiviral vector,
Wnt11 was synthesized and cloned into the pGC-LV-
GFP vector (GeneChem). Target recombinant lentiviral
vectors were also transfected in 293 cells and packaged
into virus particles (LV-Wnt11). Viral supernatant was
collected after 48 hours, and the Wnt11 gene expression
level was determined by quantitative PCR.
Transduction
hMSCs were seeded into six-well plates at a concentration
of 5 × 105 cells/ml in 2 ml medium for each well. These cells
were then transfected with virus particles encoding Wnt11
RNAi or the Wnt 11 overexpression construct at a multipli-
city of infection of 100 in complete culture medium supple-
mented with polybrene (5 μg/ml) using the Lipofectamine
2000 kit (Invitrogen) according to the manufacturer’s in-
structions. In addition, empty LV-GFP lentivirus was also
transfected and served as a control. Seventy-two hours after
transfection, the cells were collected for quantitative PCR or
western blotting assay to determine the transfection efficacy.
In addition, duplicate cells were also prepared for subse-
quent experiments.
Western blot assay
Total protein was extracted from hMSCs using the Total
Protein Extraction kit (Sigma) according to the manufac-
turer’s protocols. The protein concentration was deter-
mined with a BCA Protein Assay kit (Thermo scientific,
Rockford, Illinois, USA) according to the manufacturer’s
instructions. Then 40 μg protein were separated by SDS-
PAGE, and then were transferred onto polyvinylidene
difluoride membrane. The membrane was incubated with
mouse polyclonal antibodies specific for Wnt 11 (1:150;
Santa Cruz, CA, USA) and β-catenin (1:1000; Santa Cruz)
overnight at 4 °C. After washing with Tris-buffered saline
containing 0.1 % Tween, the membranes were incubated
with secondary antibody (1:5000; Santa Cruz) for 1 hour.
Finally, the membrane was exposed, visualized using an
enhanced chemiluminescent kit (Merck Millipore,
Eschborn, Germany) and a chemiluminescence detection
system (Bio-Rad, Hercules,California, USA). Protein bands
were quantified using the Quantity One software (Bio-
Rad).
Cell loading into the PHA/FN/ALG composite scaffold
After transduction, the hMSCs were trypsinized, rinsed,
and resuspended with fresh medium. Cells (3 × 106/ml)
were loaded into the PHA/FN/ALG composite scaffold
(0.5 cm diameter, 1.0 cm thick) and centrifuged at 50g for
1 minute. Cell-PHA/FN/ALG grafts were incubated at
5 % CO2 and 37 °C for 24 hours and then were induced
for 3 days with osteogenic medium containing 100 nM
dexamethasone, 0.2 mM ascorbate, and 10 mM β-
glycerophosphate (Sigma). Finally, the cell-PHA/FN/ALG
grafts were prepared for implantation.
Cell adhesion assay
The cell adhesion ability was assessed as described
previously [25]. Briefly, after labeling with 4′,6-diami-
dino-2-phenylindole (DAPI; Sigma) for 5 minutes,
hMSCs were seeded onto the surface of the scaffold
at a density of 10,000 cells/cm2. Subsequently, the
scaffold was centrifuged at 20 × g for 5 minutes. After
initial fluorescence readings were taken, the scaffold
was inversely centrifuged at 20 × g for another 5 mi-
nutes. Post-spin fluorescence readings were used to
determine the density of the adherent hMSCs.
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Cell proliferation assay
Evaluation of cell proliferation on the PHA/FN/ALG com-
posite scaffold was performed as reported previously [18].
Briefly, cells were seeded onto the scaffold in a 24-well
plate at a density of 3000 cells/cm and then were main-
tained in stem cell complete culture medium. Scaffold
without cells was employed as a control. After culturing
for 1, 3, 5, 7, and 9 days, 10 μl 3-(4, 5-Dimethylthiazol-2-
yl)-2, 5-diphenyltetrazolium bromide (MTT) were added
to every well. The cells were then incubated for 4 hours at
37 °C before 100 μl dimethyl sulfoxide solution was added.
After mixing for another 10 minutes, the OD of every well
was determined at 570 nm with the Thermo System (Var-
ioskan Flash, Thermo, Massachusetts, USA). A total of
three replicate wells were used to obtain the mean value.
The final OD values were normalized to the control.
S. aureus culture and animal model
The culture of S. aureus was performed following the
common procedures described in our previous study [26].
Briefly, S. aureus was grown in tryptic soy broth at 37 °C
with shaking and then centrifuged at 15,000 × g for 5 mi-
nutes, and finally resuspended in PBS. The bacterial num-
ber of the supernatant was determined the using tablet
colony counting method before use in the experiments.
An animal model of osteomyelitis was created as de-
scribed previously [27, 28]. Briefly, 2 weeks after S. aureus
(2 × 106 colony-forming units) was injected into the right
tibia of rabbit, a drastic debridement was performed on
the infectious tissues or sequestrums. Then, an infected
bone defect on the tibia (0.7 cm wide, 1.0 cm long) was
prepared for implantation surgery. In total, 35 New
Zealand rabbits (of both sexes), each weighing 2.2–2.5 kg,
were randomly divided into five groups, with seven ani-
mals in each group: group 1, blank control without graft
implantation group (BCWG); group 2, only composite
scaffold without cell implantation group (OSWG); group
3, empty lentivirus-transduced hMSCs/scaffold group
(ELSG); group 4, Wnt11-RNAi hMSCs/scaffold group
(WISG); and group 5, Wnt11 overexpressing hMSCs/scaf-
fold group (WOSG). After implantation, all rabbits re-
ceived intramuscular penicillin injections (400,000 units)
once a day for 5 consecutive days. One month later, the
rabbits were observed by standard X-ray imaging
(Siemens, Berlin, Germany) and sacrificed for subsequent
assays.
Systemic immunological reactions
At different time points after implantation, a 5 ml blood
sample was drawn from the auricular vein of each rabbit
and the final serum was used to detect the systemic im-
mune reaction. Immune cytokines, including interleukin
(IL)-2, IL-4, IL-6, IL-10, interferon gamma (IFNγ), and
TGF-β1, were measured using the ELISA Kit (R&D
Systems, Minneapolis, MN, USA) according to the man-
ufacturer’s instructions.
Quantitative RT-PCR
Total RNA was extracted from transfected cells or scaf-
folds using Trizol reagent (Takara, Tokyo, Japan) accord-
ing to the manufacturer’s protocols. After determining
the RNA concentration, RNA (1 μg) was reverse tran-
scribed into cDNA using a reverse transcription kit
(Takara). Then 1 μl cDNA was amplified with a SYBR
Green Kit (Takara) using the ABI 7500 Real-Time PCR
Detection System (Applied Biosystems, Foster, Califor-
nia) in a 20 μl reaction system. The housekeeping gene
GAPDH was employed as an internal control to
normalize the reactions. Gene expression was deter-
mined by the 2–ΔΔCt method. The primer sequences and
reaction protocol are presented in Table 1.
Radiography and micro-CT analysis
To evaluate the graft position and the general bone forma-
tion in the tibia, X-ray imaging was performed 1 month after
implantation. To assess the osteogenesis capacity of the
grafts qualitatively and quantitatively, micro-CT was per-
formed as described previously [29, 30]. The grafts were re-
moved and evaluated using micro-CT (GE Company,
London, Ontario, Canada) with the following parameters:
60 kV, 0.6 mm, 800 μA, and 150 players. More than 1000
slice images were obtained and were reconstructed at the
spatial nominal resolution of 10 μm. The newly formed
bone was separated from the grafts by setting the threshold
at 750–1200 HU. The grafts were evaluated for osteogenesis
capacity based on the following morphometric indices: bone
mineral content (BMC), bone mineral density (BMD), tissue
mineral density (TMD), tissue mineral content (TMC), bone
volume fraction (BVF), and bone volume (BV).
Gross observation and histological analysis
Rabbits were sacrificed with an overdose of sodium
pentobarbital 1 month after implantation. The specimen
was harvested for gross observation and then immedi-
ately fixed in 10 % neutral buffered formalin for 24 hours.
After sequential dehydration in ethanol solutions, the
specimen was embedded in PMMA solution for 1 week
and then sectioned to 50 μm thick by a diamond saw
(Leica-LA, Heidelberg, Baden-Wurttemberg, Germany).
The slices were stained with Villanueva-Goldner’s tri-
chrome (VG) and observed in a blind fashion. In every
group, three graft-derived slices were randomly chosen
to quantitatively analyze the newly formed bone and col-
lagen I using Image-Pro Plus (Silver Spring, Maryland,
USA) software 6.0. Osteogenesis capacity was quantified
in terms of the area of light blue and red, which
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Table 1 Primer sequences and procedure parameters used in the quantitative PCR analysis
Gene name Primer sequence Annealing temperature (Ta) (°C) Cycles
β-actin 5′-GTGGGGCGCCCCAGGCACCA-3′ (forward) 56 42
5′-CTTCCTTAATGTCACGCACGATTTC-3′ (reverse)
Wnt11 5′-TGCAGGAGCTGCAGGATGTGG-3′ (forward) 59 39
5′-AGCTCCATGGAGTGTCTCCAG-3′ (reverse)
OC 5′-ATGAGAGCCCTCACACTCCTC-3′ (forward) 60 28
5′-GCCGTAGAAGCGCCGATAGGC-3 (reverse)
Runx-2 5′-ACGACAACCGCACCATGGT-3′ (forward) 60 28
5′-CTGTAATCTGACTCTGTCCT-3′ (reverse)
ALP 5′-TGGAGCTTCAGAAGCTCAACACCA-3′ (forward) 58 30
5′-ATCTCGTTGTCTGAGTACCAGTCC-3′ (reverse)
Osterix 5′-GCAGCTAGAAGGGAGTGGTG-3′ (forward) 58 42
5′-GCAGGCAGGTGAACTTCTTC-3′ (reverse)
Collagen I 5′-CCTGAGCCAGCAGATTGA-3′ (forward) 59 29
5′-TCCGCTCTTCCAGTCAG-3′ (reverse)
BSP 5′-AAGGCTACGATGGCTATGATGGT-3′ (forward) 61 30
5′-AATGGTAGCCGGATGCAAAG-3′ (reverse)
Fig. 1 hMSCs were cultured in vitro and infected with lentiviral vectors targeting Wnt11. a Passage 0 hMSCs show the typical shape of MSCs.
b Representative images of hMSCs with lentivirus transduction. c Quantitative PCR assay of the Wnt11 gene expression level in Wnt11 RNAi-expressing
or Wnt1-overexpressing hMSCs after transduction; an empty vector expressing enhanced GFP served as a control. d Western blot assay of the Wnt11
protein expression of Wnt11 RNAi-expressing or Wnt1-overexpressing hMSCs after transduction; an empty vector expressing enhanced GFP served as
a control. e Quantitative analysis of the relative protein level of Wnt11; results were based on the density and normalized to β-actin. Data presented as
mean ± SD. *p <0.05, **p <0.01 and ***p <0.001 compared with empty vector control. Scale bar = 50 μm
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represented collagen I and newly formed trabecular
bone, respectively [31].
Statistical analysis
Data are presented as the mean ± standard deviation
(SD). Statistical analysis for differences between groups
was performed using one-way analysis of variance. In
addition, an independent-samples t test was used to
compare any two groups. p <0.05 was considered statis-
tically significant.
Results
hMSC culture, transfection and transfection efficiency
hMSCs (Fig. 1a) were cultured and passaged when they
reached 90 % confluence. Passage 1 cells were trans-
fected with pGC-LV-GFP vectors designed to overex-
press or silence Wnt11 (Fig. 1b). After transfection, all
of the cells, which received different treatments, were
used to determine transfection efficiency by quantitative
PCR and western blot assay (Fig. 1c–e). Quantitative
PCR indicated that lentivirus-mediated Wnt11 RNAi in
hMSCs significantly diminished the Wnt11 gene expres-
sion level in comparison with the control, whereas the
hMSCs designed to overexpress Wnt11 showed signifi-
cantly higher expression levels than the control cells (empty
lentivirus transduction): the suppression or stimulation rate
was 57 % and 260 % after transfection, respectively (Fig. 1c).
Significant differences in Wnt11 expression were found be-
tween the RNAi group and the overexpression and control
groups (Fig. 1c). Furthermore, western blot analysis also re-
vealed significant downregulation of Wnt11 protein levels
in the RNAi group and upregulation in the overexpression
group when compared with the control group (Fig. 1d, e).
The results suggest that lentivirus-mediated Wnt11
RNAi may successfully inhibit Wnt11 expression. Fur-
thermore, the lentivirus-mediated Wnt11 overexpression
construct could increase the Wnt11 level effectively both
at the mRNA and protein levels.
Cell adhesion assay and cell proliferation assay
The OD value reflects metabolically active cells. As
shown in Fig. 2a, hMSCs loading on the composite scaf-
folds showed a gradual increase in metabolically activity
over time. At any time point, different hMSCs displayed
similar metabolically active, and no significant differ-
ences among them could be found (p >0.05) (Fig. 2a).
Fig. 2 Proliferation and adhesion assay of hMSCs on the surface of PHA/FN/ALG composite scaffolds. a hMSC proliferation assay. b hMSC adhesion
assay. c Distribution of DAPI-labeled hMSCs adhered to the scaffolds. Data presented as mean ± SD. #p >0.05. Scale bar = 100 μm. hMSC human
mesenchymal stem/stromal cell, OD optical density
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The strength of cell adhesion was determined by
measuring the density of fluorescently labeled cells after
centrifugation. The adhesive cell number was calculated
and standardized by the fluorescent difference between
the initial readings and the second readings. The results
showed that the composite scaffolds exhibited similar
capacity to bind to different hMSCs; no significant dif-
ferences could be observed (p >0.05) (Fig. 2b, c).
Cell loading in scaffolds and implantation
As shown in the schematic diagram, PHA displayed a
porous and crude construction, but after sequential sur-
face decoration with ALG and FN, PHA formed a com-
paratively smooth surface (Fig. 3a, b). Those transfected
hMSCs still showed a spindle-like shape and then were
seeded on the scaffolds as seed cells (Fig. 3c). Two weeks
after S. aureus injection, the tibia became infectious
before implantation (Fig. 3d). After extensive debridement,
infectious tissues and sequestrums were cleared out to
prepare the graft bed (1.0 cm × 0.6 cm) (Fig. 3d, e). Those
scaffolds were implanted into the bone graft bed for
subsequent evaluation (Fig. 3d, e).
Systemic immunological reactions
Three rabbits expired during the experiments: one died
pre implantation and two died post implantation. After
implantation, the ELISA results of serum samples indi-
cated a gradual decline in the IL-2, IL-4, IL-6, IL-10,
IFNγ, and TGF-β1 levels (Fig. 4a–f ). Interestingly, these
inflammatory cytokines declined more significantly in
the first 3 days post implantation than in the subsequent
days (Fig. 4a–f ).
Evaluation of osteogenesis by quantitative RT-PCR
To investigate osteogenesis in the infected bone defect at
gene level, quantitative RT-PCR was performed at 1 month
post implantation. As shown in Fig. 5, all six osteogenic-
related genes (ALP, OC, Runx-2, BSP, Collagen I, and
Osterix) displayed a similar expressional trend among dif-
ferent groups. Nearly every gene displayed high levels in
WOSG, low levels in WISG, and an intermediate level in
ELSG. Furthermore, except for changes in OC, BSP, or
Osterix between ELSG and WISG, significant differences
were observed between any other two groups for each
gene (p <0.05).
Radiography
Radiographic standard X-ray imaging indicated that the
radio-opaque area or the radiopacity at the original bone
defect sites could be visualized clearly (Fig. 6a). The
radiographic findings revealed weak infection signs,
including small sequestration and periosteal reaction
around the grafts or the defect places (Fig. 6a). However,
it was interesting to note that the radio-translucent area
at the original defect bed decreased gradually in the
group order BCWG >OSWG >WISG > ELSG >WOSG
(Fig. 6a).
To further analyze the osteogenic capacity, micro-CT
was carried out to determine the quality and quantity of
osteogenesis capacity (Fig. 6b, c). From the axial view,
coronal view, and three-dimensional view, the results
demonstrated that the bone defects had been repaired
structurally to different degrees (Fig. 6b, c). For the
quantity of regenerated bone in the scaffold, the data
indicated that all six indexes of osteogenesis in ELSG
were significantly higher than in both BCWG and
OSWG (p >0.05, Fig. 6b, c). The results quantitatively
further revealed that all six indexes in WOSG were
significantly higher than those in both ELSG and
WISG (p <0.05, Fig. 6b, c). Moreover, the osteogen-
esis indexes in ELSG were also higher than those in
WISG, and significant differences could be observed in
the indexes of BV, BVF, and TMD (p <0.05, Fig. 6b, c), but
did not in the BMC, BMD, and TMC indexes (p >0.05,
Fig. 6b, c).
Fig. 3 PHA was modified with FN and ALG and was transplanted into the infected bone defect after loading with Wnt11-modified MSCs. a Gross
appearance of PHA. b Schematic illustration of PHA modified with FN and ALG. c Representative shape of the transfected MSCs. d An infected bone
defect (1.0 cm long and 0.5 cm in width) was made for implantation. e PHA/FN/ALG with or without Wnt11-modified MSCs were transplanted into
the bone defect site. Scale bar = 50 μm. rFN recombinant fibronectin, PHA porous hydroxyapatite
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Gross observation
Gross morphology was observed at 1 month after
implantation (Fig. 7). In BCWG, no newly formed bone
was observed in the original lacuna of the bone defect, with
the exception of a very small amount of inflammatory
fibrous tissue (Fig. 7a). As for OSWG, fractures could
be observed on the surface of the scaffold and no sig-
nificant bone-like hard tissue formed, with the excep-
tion of a large amount of inflammatory granulation
tissue (Fig. 7b). In ELSG, the scaffold was intact and
surrounded with a moderate amount of inflammatory
granulation tissue (Fig. 7c). However, the scaffold in
WISG was covered by more inflammatory granulation
and purulent tissue; moreover, the surface of the
defect was vague between the boundary between the
scaffold and the tibia (Fig. 7d). Interestingly, the
defect region in WOSG was filled with the intact
scaffold, which was attached with fibrous tissue, and
the boundary between the scaffold and the tibia com-
pletely vanished (Fig. 7e).
Histological assessment
To analyze the osteogenesis capacity, VG stain was
employed to microscopically detect hydroxyapatite, colla-
gen I and newly formed trabecular bone, which were dyed
black, blue or purple and red, respectively (Fig. 8a). The
Fig. 4 Systemic immunological reactions were detected postoperatively, and the serum concentrations of IL-2 a, IL-4 b, IL-6 c, IL-10 d, IFNγ e, and
TGF-β1 f were measured at 0, 1, 2, 3, 4, 7, and 14, 28 days after transplantation. No significant differences existed between any two groups at the same
time points (p >0.05, n = 3). Data presented as mean ± SD. BCWG blank control without grafts implantation group, ELSG empty lentiviral vectors trans-
duction hMSCs/scaffold group, IFNγ interferon gamma, IL interleukin, OSWG only scaffold without cells implantation group, TGF-β1 transforming growth
factor beta-1, WISG Wnt11 RNAi hMSCs/scaffold group, WOSG Wnt11-overexpressing hMSCs/scaffold group
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BCWG grafts demonstrated almost no collagen I or newly
formed trabecular bone in the defect bed (Fig. 8a). For
OSWG, besides very little collagen I, no trabecular bone
could be observed in the macropores of the scaffolds
(Fig. 8a). As for the other three groups, when compared
with WISG, ELSG showed significantly more trabecular
bone but less collagen I appeared in the scaffold (Fig. 8a,
b). However, more collagen I and newly formed bone
were observed in WOSG than in both ELSG and WISG
(p <0.0001, Fig. 8a, b).
Discussion
In clinical practice, quite a few open fractures generally
develop into infected nonunion [32]. Studies have con-
firmed that S. aureus is the main pathogenic bacterium
which causes infected bone nonunion or osteomyelitis [8].
During debridement, nearly all dead bone or tissue needs
to be eliminated, which inevitably leads to infected bone
defect [33]. In this study, rabbits were injected in the tibia
with S. aureus to induce the pathogenesis of osteomyelitis
disease [34]. In the early stage after implantation, serum
inflammatory markers indicated significant highly sys-
temic inflammation reaction in the infected rabbits. The
results from X-ray imaging, gross observation, systemic
immunological factors, and subsequent histological
evaluation verified that the rabbits exhibited characteris-
tics of infected bone defect. Those results suggested that
an infected bone defect model was reliably made and
could be used to evaluate bone formation of tissue-
engineered bone.
The defect size of the bone defect model often ranged
from 0.5 to 2.0 cm. In the present study, rabbits were
treated by radical debridement to provide a bone defect
1.0 cm long. In addition, one study found that PHA
without cells displayed no obvious bone repair function
in vivo [11]. In the blank control group of this study, the
results of micro-CT and histological analysis also sup-
ported this finding, whereas other hMSC-containing
groups showed fine bone repair efficiency comparatively.
Hence, in this study, the implanted tissue-engineered
bone played an essential role in the bone repair process.
Current scaffold materials are not perfect for treating
infected bone defect [14]. To obtain good scaffolds,
researchers often modify existing materials by adding
metal components such as zinc or titanium or other
materials to endow the original scaffold with potent anti-
biotic efficiency [25, 35]. However, modified scaffolds
could produce potential cytotoxicity or biocompatibility
problems [36]. Hence, developing optimal scaffolds for
treating infected bone defect is necessary before clinical
use [37]. PHA has often been adopted for bone tissue
Fig. 5 Expression of relative osteogenic genes in grafts 1 month post operation were tested by quantitative PCR. Data presented as mean ± SD.
*p <0.05, **p <0.01, ***p <0.001, #p >0.05; n = 3. ELSG empty lentiviral vectors hMSCs/scaffold group, WISG Wnt11 RNAi hMSCs/scaffold group,
WOSG Wnt11-overexpressing hMSCs/scaffold group
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engineering research or practical application due to its
biocompatibility and bone induction and bone conduc-
tion properties [38]. However, when it was used for
infected bone defect, PHA might have a reduced efficacy
because it does not have antibiotic activity [39]. Further-
more, when compared with collagen-coated PHA, pure
PHA is not easy for cells to adhere on, which might be a
drawback for use as a scaffold [40, 41]. Moreover, both
FN and ALG have short degradation periods and could
be absorbed easily by tissues within 1 month in vivo
[40, 42]. Hence, in this study we created a modified
PHA with FN and ALG. Because the degradation
period of PHA is longer than 4 months, PHA may still
provide a support role as a scaffold in vivo within the
1-month observation time, even though FN and ALG
have already degraded during that timeframe [43]. In
general, our studies showed no significant drawbacks
regarding the biological properties of the PHA/FN/
ALG composite scaffold. However, our study did not
completely eradicate the infected bone defect or com-
pletely repair the bone. Thus, better scaffold materials
with potent osteogenesis capacity require further inves-
tigation. Furthermore, exploring the optimization of
scaffolds with better cell–scaffold interfaces for treating
infected bone defect is another important area of future
research.
Fig. 6 Radiographic observation and micro-CT analysis on the osteogenesis of grafts 1 month post implantation. a X-ray observation. b Axial view
scanning, coronal view scanning, and three-dimensional reconstruction by micro-CT 1 month post implantation. c Quantitative analysis of osteogenesis
in grafts. Data presented as mean ± SD. *p <0.05, **p <0.01, ***p <0.001, ****p <0.0001, #p >0.05; n = 3. AV axial view, BCWG blank control without grafts
implantation group, BMC bone mineral content, BMD bone mineral density, BV bone volume, BVF bone volume fraction, CV coronal view, 3D three
dimensional, ELSG empty lentiviral vectors transduction hMSCs/scaffold group, OSWG only scaffold without cells implantation group, TMC tissue mineral
content, TMD tissue mineral density, WISG Wnt11 RNAi hMSCs/scaffold group, WOSG Wnt11-overexpressing hMSCs/scaffold group
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hMSCs are generally applied in bone tissue engineer-
ing for its multilineage differentiation capacities, and
also display encouraging results [44, 45]. However,
gene-modified hMSCs might be better for bone tissue
engineering applications even in infectious microenvi-
ronments [46]. In this study, using gene silencing
(RNAi) and gene overexpression methods based on
lentivirus mediation, we successfully illuminated the
role of the Wnt11 gene during the osteogenesis of
hMSCs in an infectious environment in vivo. After
3 days of transduction, the results of quantitative
PCR indicated that the Wnt11-RNAi hMSCs showed
significantly lower Wnt11 gene level than that of the
empty lentivirus-transduced hMSCs, and Wnt11-
overexpressing hMSCs showed significantly higher ex-
pression than the empty-lentivirus hMSCs at the
mRNA level. Additionally, these results were consist-
ent with the protein expression analysis. Hence, these
results indicated that Wnt11 expression was success-
fully modified. Furthermore, to shed light on the role
Fig. 7 Gross observation of those grafts 1 month after transplantation. a Blank control without grafts implantation group. b Only scaffold without cells
implantation group. c Empty lentiviral vectors transduction hMSCs/scaffold group. d Wnt11 RNAi hMSCs/scaffold group. e Wnt11-overexpressing
hMSCs/scaffold group
Fig. 8 Histological evaluation of grafts 1 month after implantation. a VG staining; collagen I and trabecular bone shown in blue and red,
respectively. b Quantitative analysis based on the area of new bone tissue. Data presented as mean ± SD. **p <0.01, ***p <0.001, ****p <0.0001,
#p >0.05. BCWG blank control without graft implantation group, ELSG Empty lentiviral vectors hMSCs/scaffold group, OSWG only scaffold without
cell implantation group, WISG Wnt11 RNAi hMSCs/scaffold group, WOSG Wnt11-overexpressing hMSCs/scaffold group
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of the Wnt11 gene in hMSCs, we constructed tissue-
engineered bone with PHA/FN/ALG scaffolds con-
taining different modified hMSCs in vitro. We then
transplanted these scaffolds into an infected bone de-
fect model. One month post implantation, the six ex-
amined osteogenic-related genes displayed similar
trends across groups. The gene levels were signifi-
cantly higher in WOSG but lower in WISG, when
compared with ELSG. Based on the osteogenic differ-
ences among those different groups, it might be
deducted that the Wnt11 gene plays an important
role in hMSCs during osteogenic differentiation in an
infectious environment.
Micro-CT is widely employed for the quantitative and
qualitative evaluation of newly formed bone without
physical disruption of the sample in vivo [47]. The
parameters BV, BVF, BMC, BMD, TMC, and TMD
reflect the bone quality indirectly [48]. Here, micro-
CT results also revealed that all those parameters
were significantly higher in WOSG than in any other
groups. However, in ELSG the results showed inferior
superior osteogenesis capacity compared with WISG.
Hence, the results further indicated that Wnt11 over-
expression enhanced the osteogenesis capacity of
hMSCs, but Wnt11 RNAi attenuated the capacity of
hMSCs in the infected bone defect model. Further-
more, histological analysis revealed that newly formed
collagen I and trabecular bone in WOSG grafts were
significantly higher than in the ELSG or WISG grafts.
These results further suggested that Wnt11 overex-
pression may enhance the osteogenesis of hMSCs in
the infectious environment.
As a transcription factor, TGF-β1 is involved in
immune inflammatory reactions, proliferation or differ-
entiation regulation, as well as promoting osteoblasts or
inhibiting osteoclast in proliferation in a concentration-
dependent manner [49, 50]. Here, our results showed
that these inflammatory factors were downregulated
3 days after implantation, which indicates that a serious
systematic inflammatory reaction occurred. The results
demonstrated that the infected bone defect model was
successful and an infectious microenvironment was
created.
In spite of the merits and encouraging results, however,
there are still some limitations. First, although WOSG dis-
played the strongest osteogenic potential, an obvious large
massive bone to bridge the defect region and the original
bone was not observed. Second, the in vivo inflammatory
environment of rabbits is not completely similar to that of
humans; thus, the results cannot be completely translated
to humans. Third, the “golden standard” autologous bone
graft was not performed in our model because this is a
preliminary study on infected bone defect and our aim is
to investigate the role of the Wnt11 gene in hMSCs. In
our future studies, based on the current foundation, au-
tologous bone grafting combined with larger animal
models will be investigated.
Conclusions
To our knowledge, this is the first study to investigate the
role of Wnt11 during bone formation in an infectious en-
vironment. Our results demonstrated that Wnt11 plays an
important role and may enhance the osteogenesis capacity
of hMSCs in an infected bone defect model. Our findings
may contribute to illustrating the mechanism of osteogen-
esis in an infectious environment and might provide new
mechanisms for treating infected bone defect.
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